Status:

COMPLETED

Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma(NewEC Study)

Lead Sponsor:

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Collaborating Sponsors:

Guangdong Provincial People's Hospital

Massachusetts General Hospital

Conditions:

Radiotherapy Side Effect

Chemotherapy Effect

Eligibility:

All Genders

18-80 years

Brief Summary

To provide comprehensive efficacy and safety profiles of neoadjuvant chemoradiotherapy (NCRT) versus neoadjuvant chemotherapy (NCT) versus surgery alone in resectable oesophageal carcinoma.

Detailed Description

Neoadjuvant chemotherapy (NCT) or neoadjuvant chemoradiotherapy (NCRT) has been shown to be better than surgery alone in patients with resectable oesophageal carcinoma, but higher quality evidence is ...

Eligibility Criteria

Inclusion

  • Patients with histologically documented untreated SCC or adenocarcinoma of the oesophagus or gastro-oesophageal junction.
  • Patients clinically staged as stage I-III (T1-3, N0-1 and M0) as assessed by a contrast-enhanced multislice computed tomography (CT) scan, positron emission tomography, or endoscopic ultrasonography.
  • Patients had an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2.

Exclusion

  • Patients had received any previous treatment for oesophageal cancer.
  • Patients who were unsuitable for surgery because of comorbidities.
  • Patients had evidence of distant metastatic disease by history and physical examination.

Key Trial Info

Start Date :

November 14 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2019

Estimated Enrollment :

423 Patients enrolled

Trial Details

Trial ID

NCT04027543

Start Date

November 14 2018

End Date

December 1 2019

Last Update

May 29 2020

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Massachusetts General Hospital of Harvard Medical School

Boston, Massachusetts, United States, 01748

2

Guangdong Provincial People's Hospital

Guangzhou, Guangdong, China, 510000

3

Sun Yat-Sen Memorial Hospital of Sun Yat-sen University

Guangzhou, Guangdong, China, 510000

Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma(NewEC Study) | DecenTrialz